charles river

Charles River takeover of WuXi collapses

Charles River bows to shareholder pressure and abandons its $1.6 billion takeover of WuXi PharmaTech, signalling that Western buyers may find it difficult to garner the support they need to strike deals in Asia's fast-growing economies.

August 02, 2010

Charles River buys WuXi PharmaTech in $1.6 billion deal

Pharmaceutical research company Charles River pays $1.6 billion in cash and stock to acquire Chinese outsourcing company WuXi PharmaTech two-and-a-half years after its listing in the US.

April 26, 2010

Charles River Development wins Japan deal

Nissay Asset Management selectes Charles River for comprehensive front- and middle-office software suite.

September 06, 2006